Stay updated on DSP-5336 in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a page-level update. This change signals a deployment or refresh of the page without altering the study details or visible fields.
    Difference
    0.0%
    Check dated 2026-05-18T03:49:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T08:19:06.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T01:32:33.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    - Added Horizon-1 Phase 1/2 study of Enzomenib (DSP-5336) in acute leukemia with multiple arms, SOC combinations, and a detailed global site list. Replaced the former DSP-5336 relapsed/refractory AML/ALL study description with the Horizon-1 protocol and expanded indications and design.
    Difference
    8%
    Check dated 2026-03-28T13:44:52.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:39:32.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible content changes.
    Difference
    0.0%
    Check dated 2026-03-06T18:39:41.000Z thumbnail image

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.